I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

Pfizer is working to get approval on a new vaccine that could protect people against Lyme disease, but the company could see pushback from the government following studies done on the vaccine. "What ...

A Lyme disease vaccine produced by Pfizer and Valneva was deemed 70 percent effective by the companies after they reviewed the results from a phase 3 trial. If approved by regulators, it would be the ...

Pfizer Inc. said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, a lackluster result as fewer-than-expected infections in the pivotal study made its potency ...

Pharmaceutical giant Pfizer PFE1.28%increase; green up pointing triangle and French vaccine maker Valneva VLA 0.29%increase; green up pointing triangle reported positive topline results from their ...

A phase 2 study of Pfizer’s atirmociclib has hit its primary endpoint, providing evidence that the CDK4 inhibitor improves progression-free survival (PFS) in second-line metastatic breast cancer. But ...

Pfizer’s revenue reached $100 billion a few years ago, driven by its dominance in coronavirus treatments and prevention. In recent times, it’s faced a drop in that demand and losses of exclusivity ...

When it comes to coding, peer feedback is crucial for catching bugs early, maintaining consistency across a codebase, and improving overall software quality. The rise of “vibe coding” — using AI tools ...

Whenever I think about the thesis for Pfizer Inc. (PFE), I can't help but ruminate over why the market has not shown much conviction despite PFE trading at valuations that are still undisputably close ...

Sanofi SA (NASDAQ: SNY) has been found to have violated the U.K.'s pharmaceutical marketing code after a senior executive made misleading claims in an October 2024 interview, prompting a complaint ...